lobbying_activities: 3014926

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3014926	5e48f4cd-493f-4f73-b620-868377f4dd46	Q2	BUCHANAN INGERSOLL & ROONEY PC	55291	GENERIC ANIMAL DRUG ALLIANCE	2023	second_quarter	PHA	Strategy development and implementation of federal government relations initiatives relating to generic animal drug industry. H.R. 1683, the Generic Animal Drug Advancement Act, all provisions; H.R. 1418, the Animal Drug User Fee Amendments of 2023, all provisions	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-07-19T12:04:46-04:00